Professional Documents
Culture Documents
FETP India
Key areas
Types of analysis
Conducting a cost effectiveness analysis
Generalized cost effectiveness
Advantages
Allows comparisons with non health programmes
Useful when intervention generates non health outcomes
Disadvantages
Controversial
Assigns a value to human life
Relevance
Programming
Adequacy
Implementation
Inputs
Programmed
resources
----------Allocated
resources
Process
Output
Norms and
procedures
Agreed
objectives /
targets
----------------Achieved
objectives /
targets
---------Applications
of norms /
procedures
Progress
Efficiency
Outcome
Impact
Effectiveness
Effectiveness
Degree of attainment of pre-determined
objectives of a programme
(e.g., in terms of reducing death / disability)
Cases
Deaths
Years of life
DALYs
Effectiveness
Obtain documented data on effectiveness
Measure effectiveness precisely
Meta analysis
Confidence intervals
Document assumptions
The cheapest way to go to the moon is to jump. However, we
dont do it because it does not work
Discounting
Ministry of health
Health system
Societal
Absorb start up costs
2. Identify interventions
Do nothing scenario
Describe components
Relate to measurable effectiveness
Intermediate outcomes
Final outcomes
Cases prevented
Life saved
YLLs
DALYs
Cost utility
4. Estimate costs
Cost of the intervention
? Cost of the disease averted
Medical costs
Non medical costs
? Productivity losses
Net costs = Cost
intervention
5. Estimate effects
Burden of disease
Incidence of disease
Incidence of complications (natural history)
Utility calculations
Effectiveness of intervention
Average
Incremental
Coverage
Discounting
Parameters to examine
Costs
ps and qs
Discounting
Effectiveness
Burden of disease
Combinations
Advanced analysis
Cost effective
Cost per DALY under 3 GDP / capita
Cost effectiveness
versus burden of disease
Cost effective intervention can prevent only
a small burden of disease
Some large sources of burden of disease may
be preventable through non cost effective
interventions
Cost effectiveness
of various health interventions
Limitations of traditional
cost-effectiveness studies
Different horizons
Different types of costs included
Different costing methods
Different discounting rates
Different outcome measures
Incremental approach
Existing interventions not reconsidered
One dimension
May not address variations by regions
Conflicts of interests
Identical horizons
Standardized approach to including costs
Unique costing methods
Standardized discounting policy
DALY as outcome measures
Null case base
Existing interventions reconsidered
Multiple dimension
Region specific
Science dissociated from advocacy
Recent concept
Difficulties in adapting theoretical concepts
Resource intensive
Single study team (at the moment)
DALY averted
Average CE
ratio
523,019,455
3,248,440
161
585,826,305
951,318
616
5,907,522,335
4,908,162
1,204
11,578,743,777
9,627,739
1,203
14,184,319,328
25,443,560
557
39,689,844,066
38,442,566
1,032
Intervention
Feasibility
Ethics
Equity
Sustainability
Acceptability